Superficial Cervical Plexus Block for Pacemaker Insertion

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01473667

Enrollment

Registered

2011-11-17

Start date

2011-11-30

Completion date

2016-09-30

Last updated

2019-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pacemaker Insertion, Pain, Regional Block

Brief summary

The purpose of this study is to investigate clinical outcomes from two current standard of care pain control procedures performed for patients undergoing pacemaker insertion.

Interventions

PROCEDURESuperficial Cervical Plexus Block (SCP) block

SCP block using 10-15ml of 1% Ropivacaine

PROCEDURELocal site infiltration

Local site infiltration using 2% lidocaine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Age 18-100 years old * Registered patients at Mayo Clinic in Florida scheduled to undergo primary insertion of pacemaker

Exclusion criteria

* Emergency placement of pacemaker * Sub-pectoral placement of pacemaker * Patients with history of chronic pain * Patients with anatomical abnormality or disruption to the pacemaker insertion site or site of block placement * Patients with allergy to local anesthetic

Design outcomes

Primary

Measure	Time frame
To decrease opioid requirements after Pacemaker insertion	first 24 hrs post pacemaker insertion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026